M

02629

MIRXES-B

12.410

0.0000.00%
Suspension09:20 04/02 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE15.800/12.410
TODAY RANGE12.380-17.080
VOL0
MARKET CAP3.70B
52 WEEK RANGE12.280-77.300
AVG VOL (3M)4.80M
% TURNOVER0.00%
TURNOVER800.00M
P/E (TTM)-6.185
% RANGE30.21%
EPS(TTM)-2.006
P/E(FORWARD)-7.575
P/B4.514
BVPS2.749
DIVIDEND--
P/S22.252
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.70B
SHARES OUTSTANDING298.23M
NEXT EARNINGS--
FREE FLOAT298.23M
LOT SIZE100
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

昊海生物科技

06826

-1.16%
22.240

W

Wuxi Apptec

02359

+0.81%
124.900

泰格醫藥

03347

-2.91%
42.700

昭衍新藥

06127

+1.43%
21.220

康龍化成

03759

+0.48%
20.980

01521

--

01035

--

C

China Health Group

08225

0.00%
0.146

銘源醫療

00233

0.00%
0.230

中國再生醫學-舊

08572

0.00%
0.010

02181

--

維亞生物

01873

-1.99%
1.970

08158

--

B

BioDlink International

01875

-3.66%
5.000

華領醫藥-B

02552

-0.27%
3.650

M

MicroPort NeuroScientific

02172

-1.46%
10.810

康寧傑瑞製藥-B

09966

-0.11%
9.040

中國抗體-B

03681

0.00%
1.760

L

Lepu Biopharma

02157

+0.65%
6.150

01167

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.